180 related articles for article (PubMed ID: 23426901)
1. Role of ATF7-TAF12 interactions in the vitamin D response hypersensitivity of osteoclast precursors in Paget's disease.
Teramachi J; Hiruma Y; Ishizuka S; Ishizuka H; Brown JP; Michou L; Cao H; Galson DL; Subler MA; Zhou H; Dempster DW; Windle JJ; Roodman GD; Kurihara N
J Bone Miner Res; 2013 Jun; 28(6):1489-500. PubMed ID: 23426901
[TBL] [Abstract][Full Text] [Related]
2. Increased IL-6 expression in osteoclasts is necessary but not sufficient for the development of Paget's disease of bone.
Teramachi J; Zhou H; Subler MA; Kitagawa Y; Galson DL; Dempster DW; Windle JJ; Kurihara N; Roodman GD
J Bone Miner Res; 2014 Jun; 29(6):1456-65. PubMed ID: 24339057
[TBL] [Abstract][Full Text] [Related]
3. Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's Disease.
Kurihara N; Reddy SV; Araki N; Ishizuka S; Ozono K; Cornish J; Cundy T; Singer FR; Roodman GD
J Bone Miner Res; 2004 Jul; 19(7):1154-64. PubMed ID: 15176999
[TBL] [Abstract][Full Text] [Related]
4. (23S)-25-Dehydro-1{alpha}-hydroxyvitamin D3-26,23-lactone, a vitamin D receptor antagonist that inhibits osteoclast formation and bone resorption in bone marrow cultures from patients with Paget's disease.
Ishizuka S; Kurihara N; Reddy SV; Cornish J; Cundy T; Roodman GD
Endocrinology; 2005 Apr; 146(4):2023-30. PubMed ID: 15618361
[TBL] [Abstract][Full Text] [Related]
5. TBK1 mediates critical effects of measles virus nucleocapsid protein (MVNP) on pagetic osteoclast formation.
Sun Q; Sammut B; Wang FM; Kurihara N; Windle JJ; Roodman GD; Galson DL
J Bone Miner Res; 2014 Jan; 29(1):90-102. PubMed ID: 23794264
[TBL] [Abstract][Full Text] [Related]
6. Experimental models of Paget's disease.
Kurihara N; Zhou H; Reddy SV; Garcia Palacios V; Subler MA; Dempster DW; Windle JJ; Roodman GD
J Bone Miner Res; 2006 Dec; 21 Suppl 2():P55-7. PubMed ID: 17229020
[TBL] [Abstract][Full Text] [Related]
7. Contributions of the measles virus nucleocapsid gene and the SQSTM1/p62(P392L) mutation to Paget's disease.
Kurihara N; Hiruma Y; Yamana K; Michou L; Rousseau C; Morissette J; Galson DL; Teramachi J; Zhou H; Dempster DW; Windle JJ; Brown JP; Roodman GD
Cell Metab; 2011 Jan; 13(1):23-34. PubMed ID: 21195346
[TBL] [Abstract][Full Text] [Related]
8. Increased S1P expression in osteoclasts enhances bone formation in an animal model of Paget's disease.
Nagata Y; Miyagawa K; Ohata Y; Petrusca DN; Pagnotti GM; Mohammad KS; Guise TA; Windle JJ; David Roodman G; Kurihara N
J Cell Biochem; 2021 Apr; 122(3-4):335-348. PubMed ID: 33107091
[TBL] [Abstract][Full Text] [Related]
9. Expression of measles virus nucleocapsid protein in osteoclasts induces Paget's disease-like bone lesions in mice.
Kurihara N; Zhou H; Reddy SV; Garcia Palacios V; Subler MA; Dempster DW; Windle JJ; Roodman GD
J Bone Miner Res; 2006 Mar; 21(3):446-55. PubMed ID: 16491293
[TBL] [Abstract][Full Text] [Related]
10. Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotype.
Kurihara N; Reddy SV; Menaa C; Anderson D; Roodman GD
J Clin Invest; 2000 Mar; 105(5):607-14. PubMed ID: 10712432
[TBL] [Abstract][Full Text] [Related]
11. Osteoclasts formed by measles virus-infected osteoclast precursors from hCD46 transgenic mice express characteristics of pagetic osteoclasts.
Reddy SV; Kurihara N; Menaa C; Landucci G; Forthal D; Koop BA; Windle JJ; Roodman GD
Endocrinology; 2001 Jul; 142(7):2898-905. PubMed ID: 11416009
[TBL] [Abstract][Full Text] [Related]
12. Osteoclast inhibitory peptide-1 (OIP-1) inhibits measles virus nucleocapsid protein stimulated osteoclast formation/activity.
Shanmugarajan S; Youssef RF; Pati P; Ries WL; Rao DS; Reddy SV
J Cell Biochem; 2008 Jul; 104(4):1500-8. PubMed ID: 18348201
[TBL] [Abstract][Full Text] [Related]
13. Osteoclast-derived IGF1 is required for pagetic lesion formation in vivo.
Miyagawa K; Ohata Y; Delgado-Calle J; Teramachi J; Zhou H; Dempster DD; Subler MA; Windle JJ; Chirgwin JM; Roodman GD; Kurihara N
JCI Insight; 2020 Mar; 5(6):. PubMed ID: 32078587
[TBL] [Abstract][Full Text] [Related]
14. 1,25-Dihydroxyvitamin D3 hypersensitivity of osteoclast precursors from patients with Paget's disease.
Menaa C; Barsony J; Reddy SV; Cornish J; Cundy T; Roodman GD
J Bone Miner Res; 2000 Feb; 15(2):228-36. PubMed ID: 10703924
[TBL] [Abstract][Full Text] [Related]
15. Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL.
Neale SD; Smith R; Wass JA; Athanasou NA
Bone; 2000 Sep; 27(3):409-16. PubMed ID: 10962353
[TBL] [Abstract][Full Text] [Related]
16. NFAM1 signaling enhances osteoclast formation and bone resorption activity in Paget's disease of bone.
Sambandam Y; Sundaram K; Saigusa T; Balasubramanian S; Reddy SV
Bone; 2017 Aug; 101():236-244. PubMed ID: 28506889
[TBL] [Abstract][Full Text] [Related]
17. Osteoclast-derived IGF1 induces RANKL production in osteocytes and contributes to pagetic lesion formation.
Miyagawa K; Tenshin H; Mulcrone PL; Delgado-Calle J; Subler MA; Windle JJ; Chirgwin JM; Roodman GD; Kurihara N
JCI Insight; 2023 Jul; 8(14):. PubMed ID: 37338990
[TBL] [Abstract][Full Text] [Related]
18. Measles virus nucleocapsid protein increases osteoblast differentiation in Paget's disease.
Teramachi J; Nagata Y; Mohammad K; Inagaki Y; Ohata Y; Guise T; Michou L; Brown JP; Windle JJ; Kurihara N; Roodman GD
J Clin Invest; 2016 Mar; 126(3):1012-22. PubMed ID: 26878170
[TBL] [Abstract][Full Text] [Related]
19. Paget's disease-a VDR coactivator disease?
Kurihara N; Ishizuka S; Demulder A; Menaa C; Roodman GD
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):321-5. PubMed ID: 15225793
[TBL] [Abstract][Full Text] [Related]
20. Measles virus nucleocapsid protein, a key contributor to Paget's disease, increases IL-6 expression via down-regulation of FoxO3/Sirt1 signaling.
Wang FM; Sarmasik A; Hiruma Y; Sun Q; Sammut B; Windle JJ; Roodman GD; Galson DL
Bone; 2013 Mar; 53(1):269-76. PubMed ID: 23262029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
